StockData
Lisata Therapeutics, Inc. logo

Lisata Therapeutics, Inc. (LSTA) stock

LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.98−0.06 (-5.76%)

Close on Nov 18, 2026Market cap $8.83MP/E –Yield –

Lisata Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Lisata Therapeutics's pe ratio was 1.5× on Feb 28, 2019.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Feb 28, 20191.5×+0.1
2018Dec 31, 20181.4×–

More Lisata Therapeutics figures

See a number that looks wrong?